Jiangsu Hengrui Pharmaceuticals (01276) recommends adopting the A-share employee stock ownership plan for 2025.
Hengrui Medicine (01276) announced that it has approved at the board meeting held on August 20, 2025...
Jiangsu Hengrui Pharmaceuticals (01276) announced that its employee stock ownership plan was approved at the board meeting held on August 20, 2025. The employee stock ownership plan is subject to approval by the company's shareholders' meeting before it can take effect.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
